NEVUS FLAMMEUS

Clinical trials for NEVUS FLAMMEUS explained in plain language.

Never miss a new study

Get alerted when new NEVUS FLAMMEUS trials appear

Sign up with your email to follow new studies for NEVUS FLAMMEUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New light therapy could fade Port-Wine stains

Disease control Recruiting now

This study tests a treatment called Hemoporfin photodynamic therapy for port-wine birthmarks. It involves injecting a drug that is activated by green light to target the birthmark. 84 adults aged 18 to 75 will receive up to 3 treatment cycles to see which light dose works best an…

Matched conditions: NEVUS FLAMMEUS

Phase: PHASE2 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC

NEVUS FLAMMEUS

Get alerted when new NEVUS FLAMMEUS trials appear

New light therapy could fade Port-Wine stains